BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 16311600)

  • 1. Impaired assembly of the major histocompatibility complex class I peptide-loading complex in mice deficient in the oxidoreductase ERp57.
    Garbi N; Tanaka S; Momburg F; Hämmerling GJ
    Nat Immunol; 2006 Jan; 7(1):93-102. PubMed ID: 16311600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective loading of high-affinity peptides onto major histocompatibility complex class I molecules by the tapasin-ERp57 heterodimer.
    Wearsch PA; Cresswell P
    Nat Immunol; 2007 Aug; 8(8):873-81. PubMed ID: 17603487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Redox regulation of peptide receptivity of major histocompatibility complex class I molecules by ERp57 and tapasin.
    Kienast A; Preuss M; Winkler M; Dick TP
    Nat Immunol; 2007 Aug; 8(8):864-72. PubMed ID: 17603488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of ERp57 and tapasin in the generation of MHC class I-peptide complexes.
    Garbi N; Hämmerling G; Tanaka S
    Curr Opin Immunol; 2007 Feb; 19(1):99-105. PubMed ID: 17150345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The optimization of peptide cargo bound to MHC class I molecules by the peptide-loading complex.
    Elliott T; Williams A
    Immunol Rev; 2005 Oct; 207():89-99. PubMed ID: 16181329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular architecture of the MHC I peptide-loading complex: one tapasin molecule is essential and sufficient for antigen processing.
    Hulpke S; Baldauf C; Tampé R
    FASEB J; 2012 Dec; 26(12):5071-80. PubMed ID: 22923333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aggregate formation by ERp57-deficient MHC class I peptide-loading complexes.
    Stepensky D; Bangia N; Cresswell P
    Traffic; 2007 Nov; 8(11):1530-42. PubMed ID: 17822402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ERp57 interacts with conserved cysteine residues in the MHC class I peptide-binding groove.
    Antoniou AN; Santos SG; Campbell EC; Lynch S; Arosa FA; Powis SJ
    FEBS Lett; 2007 May; 581(10):1988-92. PubMed ID: 17467700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The aminopeptidase ERAAP shapes the peptide repertoire displayed by major histocompatibility complex class I molecules.
    Hammer GE; Gonzalez F; Champsaur M; Cado D; Shastri N
    Nat Immunol; 2006 Jan; 7(1):103-12. PubMed ID: 16299505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of major histocompatibility complex Class I antigen presentation by hepatitis C virus core protein in myeloid dendritic cells.
    O'Beirne J; Mitchell J; Farzaneh F; Harrison PM
    Virology; 2009 Jun; 389(1-2):1-7. PubMed ID: 19409594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Redox regulation facilitates optimal peptide selection by MHC class I during antigen processing.
    Park B; Lee S; Kim E; Cho K; Riddell SR; Cho S; Ahn K
    Cell; 2006 Oct; 127(2):369-82. PubMed ID: 17055437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tapasin enhances MHC class I peptide presentation according to peptide half-life.
    Howarth M; Williams A; Tolstrup AB; Elliott T
    Proc Natl Acad Sci U S A; 2004 Aug; 101(32):11737-42. PubMed ID: 15286279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction and destruction of MHC class I in the peptide-loading complex.
    Hammer GE; Shastri N
    Nat Immunol; 2007 Aug; 8(8):793-4. PubMed ID: 17641657
    [No Abstract]   [Full Text] [Related]  

  • 14. Epitopes of the class I major histocompatibility complex (MHC-I) recognized in the syngeneic or allogeneic context predominantly linked to antigenic peptide loading to its binding groove.
    Nguyen van Binh P; Duc HT
    Clin Exp Immunol; 2006 Aug; 145(2):372-9. PubMed ID: 16879259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of co-expression costimulatory molecule CD80 on uptake of antigen peptide-MHC class I-GFP complex by specific T cells.
    Liu X; Zhang L; Zhang X; Yu H; Zhao X; Lu J; Qian G; Ge S
    Int J Oncol; 2007 Jun; 30(6):1389-96. PubMed ID: 17487359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathways of antigen processing and presentation.
    Watts C; Powis S
    Rev Immunogenet; 1999; 1(1):60-74. PubMed ID: 11256573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calreticulin maintains the low threshold of peptide required for efficient antigen presentation.
    Fu H; Liu C; Flutter B; Tao H; Gao B
    Mol Immunol; 2009 Oct; 46(16):3198-206. PubMed ID: 19748124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In the absence of aminopeptidase ERAAP, MHC class I molecules present many unstable and highly immunogenic peptides.
    Hammer GE; Gonzalez F; James E; Nolla H; Shastri N
    Nat Immunol; 2007 Jan; 8(1):101-8. PubMed ID: 17128277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of MHC class I-restricted antigen processing and cross-presentation.
    Cresswell P; Ackerman AL; Giodini A; Peaper DR; Wearsch PA
    Immunol Rev; 2005 Oct; 207():145-57. PubMed ID: 16181333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The complex route to MHC class I-peptide complexes.
    Elliott T; Neefjes J
    Cell; 2006 Oct; 127(2):249-51. PubMed ID: 17055423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.